18 studies found for:    Open Studies | "Respiratory Syncytial Virus Infections"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Respiratory Syncytial Virus Infections" (18 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: Placebo;   Drug: JNJ-53718678
2 Recruiting Study to Evaluate the Efficacy and Safety of REGN2222, for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: REGN2222
3 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
4 Recruiting Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immuno Compromised Children With Synagis
Condition: Respiratory Syncytial Virus Infection
Intervention:
5 Recruiting A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171
Condition: Respiratory Syncytial Virus Infection
Interventions: Biological: ALX-0171;   Other: Placebo
6 Not yet recruiting A Study of AK0529 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: AK0529
7 Recruiting Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: MVA BN RSV;   Other: Placebo
8 Recruiting Safety, Tolerability and PK Study of AK0529 in Healthy Human
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: AK0529;   Drug: Placebo
9 Recruiting A Study of ALS-008176 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
10 Unknown  RSV Observational Study 2
Condition: Respiratory Syncytial Virus Infections
Intervention: Procedure: Blood sample
11 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
12 Recruiting Respiratory Syncytial Virus - RSV Protocol
Conditions: Bone Marrow Transplant Infection;   Infection in Marrow Transplant Recipients;   Respiratory Syncytial Virus Infections;   Respiratory Syncytial Virus Pneumonia;   Cancer;   Acute Leukemia
Intervention: Drug: Ribavirin
13 Recruiting Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV MEDI ΔM2-2 vaccine;   Biological: Placebo vaccine
14 Recruiting Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
Condition: Respiratory Syncytial Virus Infections
Intervention:
15 Unknown  Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Conditions: Respiratory Distress Syndrome, Adult;   Respiratory Syncytial Virus Infections;   Pneumonia;   Acute Lung Injury
Intervention:
16 Recruiting GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: GS-5806;   Drug: Placebo
17 Recruiting TGF-(Beta) and Susceptibility to RSV
Conditions: Respiratory Syncytial Virus;   Asthma
Intervention:
18 Unknown  RSV Disease in the Elderly
Conditions: Respiratory Infections, Acute;   Respiratory Syncytial Virus
Intervention:

Indicates status has not been verified in more than two years